Continued Momentum in Pharmacy, Medical Device, and Radiology Segments Helped Drive 28% Increase in Annual Revenue With a 37% Revenue CAGR From 2019 to 2022 (SAN DIEGO, CA) – XiFin,
In the coming years more retail pharmacy brands will adopt technology to gain a competitive edge Those years have been “transformative,” taking the retail pharmacy sector beyond its traditional role
HIT Consultant: Pharmacies are now the “front door” to health care.” Some people think of retail pharmacists as standing behind the counter bottling pills, answering insurance questions, or discussing side
An open letter to pharmacists: As a fellow pharmacist, I’m thrilled to see how the profession has embraced clinical services in the retail space.
OmniSYS is proud to announce our recognition as a pharmacy technology and automation leader, chosen by Drug Store News as a retail pharmacy award winner for the 2022 REX Awards!
Pharmacy Times recap of the current status of the test to treat initiative, featuring OmniSYS CIO David Pope, PharmD, CDE. Despite AMA pushback, pharmacy is ready for test and treat.
The Drug Topics editorial board, including OmniSYS CIO David Pope, PharmD, CDE responds to the AMA’s recent negative statement regarding the test to treat initiative outlined by the Biden Administration.
Pharmacy Times interview with OmniSYS CIO David Pope and Christina Madison, The Public Health Pharmacist, discussing the new test to treat plan mentioned in the 2022 State of the Union.
Test to treat in pharmacy: Drug Topics asked OmniSYS chief innovation officer David Pope for his thoughts regarding test to treat after President Biden’s 2022 State of the Union address.
Clinical pharmacy is in demand and sustainable pharmacy technology makes it happen. Pharmacies must make the most of current technology investments, and building upon them for an automated, efficient future.
XIFIN’s acquisition of OmniSYS is the latest evidence that pharmacies are the front door to healthcare. Uniting lab data with pharmacy data is a game-changer, for now and the future.
Great news! We’ve enhanced our Medicare Part D Comparison Tool to better support your pharmacy during open enrollment, included free of charge with our clinical services and patient communications solutions.
Copyright 2023 Omnisys, LLC. All rights reserved.
